Category Archives: Health and Pharmaceuticals


Types of Covid Vaccines and How Soon Can You Get Inoculated

Pharmaceutical companies around the world are rushing to manufacture and distribute a viable vaccine. There are five main approaches being taken to develop a vaccine against SARS-CoV-2/COVID19, with several biotechnology companies, academic organisations and pharmaceutical companies employing different technologies in the race to bring their vaccine candidate to clinical trials. The World Health Organization hopes that a vaccine […]


Xenopat: Your Tumor in a Mouse

Labcritics visited Xenopat, an innovative company dedicated to the orthotopic implantation of human tumors in mice. This technology allows Xenopat to offer services to companies developing new anticancer drugs and personalized cancer treatments. We had the pleasure of speaking with Dr. Anna Portela, CEO and co-founder, and Dr. Alberto Villanueva, CSO and co-founder. For more […]


Teresa Tarragó: “Crowdfunding is a Source of Financing for Early Stage Biotechs”

Labcritics was at Iproteos’ facilities talking to Teresa Tarragó, CEO and co-founder of this innovative company. Iproteos combines computational chemistry with modern synthesis methods to generate peptidomimetics with pharmacological activity against diseases such as schizophrenia. We had the opportunity to know about the possibilities of crowdfunding for biotech projects and the technology used in their laboratory. […]


DNA Aptamers to Replace Antibodies in Disease Detection and Treatment

Researchers from the Institute of Bioengineering and Nanotechnology (IBN) of A*STAR in Singapore have developed a better technology to detect and treat infectious diseases and cancer. The team improved the binding efficiency and nuclease resistance of aptamers, single-stranded DNAs designed to specifically target proteins, nuclei acids and cells. The study was published in the journal Scientific Reports. […]

FDA logo

FDA Approves Drug Produced in Transgenic Chicken

The Food and Drug Administration (FDA) has approved Alexion’s Kanuma (sebelipase alfa), a compound for the treatment of the rare disease lysosomal acid lipase (LAL) deficiency. This is the second time the FDA approves a drug produced in genetically engineered (GE) animals. In 2009, the pharmaceutical company GTC Biotherapeutics obtained FDA approval to commercialize the anticoagulant […]


Dendrimer Nanoparticles Successfully Deliver RNA Drug to Cancerous Liver

Researchers from the University of Texas Southwestern (UTSW) Medical Center have successfully delivered small-RNA drugs to a cancerous liver by introducing them in synthetic nanoparticles. The dendrimers didn’t damage the healthy tissues near the carcinoma. The study has been published in the journal Proceedings of the Natural Academy of Sciences. Liver cancer is the second leading cause […]

Patient iP Secures $2 Million Investment

Patient Identification Platform (PatientiP), a provider of clinical trial matching technology, has obtained $2 million in a Series A investment round. The company aims to facilitate the recruitment of individuals for clinical trials, which has become increasingly difficult due to complicated selection criteria, enrollment procedures and timelines. It is calculated that 50% of clinical trials […]